Cargando…
The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients
Prophylaxis to prevent bleeding is highly recommended for hemophilia patients. The development of new drugs and tools for modeling personalized prophylaxis provides the means for people with hemophilia to lead active lives with a quality of life comparable to that of nonhemophilic individuals. The c...
Autores principales: | Núñez, Ramiro, Álvarez-Román, María Teresa, Bonanad, Santiago, González-Porras, José Ramón, De La Corte-Rodriguez, Hortensia, Berrueco, Rubén, Jiménez-Yuste, Víctor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652116/ https://www.ncbi.nlm.nih.gov/pubmed/36452202 http://dx.doi.org/10.1055/s-0042-1757745 |
Ejemplares similares
-
Long-term impact of primary prophylaxis on joint status in patients with severe hemophilia A
por: Meijón Ortigueira, María del Mar, et al.
Publicado: (2023) -
Costs of the management of hemophilia A with inhibitors in Spain
por: Bonanad, Santiago, et al.
Publicado: (2021) -
Complications and Implant Survival of Total Knee Arthroplasty in People with Hemophilia
por: Rodriguez-Merchan, Emerito Carlos, et al.
Publicado: (2022) -
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
por: Shapiro, Amy D., et al.
Publicado: (2022) -
Optimization of prophylaxis for hemophilia A
por: Herbert, Robert D., et al.
Publicado: (2018)